![](https://webarchive.library.unt.edu/eot2008/20081019161843im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |
Public
Hearing: Use of Color on Pharmaceutical
Product Labels, Labeling and Packaging
March 7, 2005,
NIH Campus, Bethesda, MD.
The agenda for the Part 15 Hearing on Use of Color on
Pharmaceutical Labeling and Packaging is below. The meeting is
scheduled to be held on March 7 from 8 am – 2 pm. It will be held at
the Lister Hill Auditorium on the NIH Campus in Bethesda Maryland.
Please note that parking is scarce on the NIH campus and that strict
security procedures are in place. It is recommended that
speakers/observers take the Metro to the Hearing, if possible.
The FDA expert panel will consist of:
Dr. Paul Seligman, (Director, Office of Pharmacoepidemiology and
Statistical Science, CDER)
Dr. Robert Meyer (Director, Office of Drug Evaluation II, CDER )
Dr. Wiley Chambers, (Deputy Director, Division of Anti-Inflammatory,
Analgesic and Ophthalmic Drug Products, CDER )
Dr. Peter Carstensen, (Senior Systems Engineer, Division of Device
User Programs and Systems Analysis, CDRH)
Ms. Carol Holquist, Director, Division of Medication Error
Prevention and Technical Support, CDER)
Agenda
8:00 – Dr. Paul Seligman - Welcome
8:10 – Carol Holquist –Use of Color on Pharmaceutical Labeling and
Packaging – an Overview
8:20 – Mr. Charles Meyers - American Society of Health Systems
Pharmacists
8:50 – Dr. Mary Baker, Dr. Thomas Willer - Hospira, Inc
9:30 – Dr. Eric Sheinin – United States Pharmacopeia
10:00 – Break
10:30 – Dr. Michael Cohen – Institute for Safe Medication Practices
11:00 – Dr. Mary Ann McElligott - Novo Nordisk
11:45 – Dr. Joseph Cranston – American Medical Association
12:15 – Dr. James Broselow
12:45 – Dr. Frank Kyle – American Dental Association
1:15 – Dr. Allan Jensen – American Academy of Ophthalmology
1:45 – Dr. Paul Seligman - Closing Remarks
Transcript
![](https://webarchive.library.unt.edu/eot2008/20081019161843im_/http://www.fda.gov/cder/graphics/pdf.gif)
Presentations
-
- Use of Color on Pharmaceutical Product
Labels, Labeling and Packaging, Mary Baker,
- The Broselow-Luten System, James Broselow,
MD [PPT]
- Managing pharmaceutical package labels with color to reduce
medication errors, Michael R. Cohen, Institute for Safe Medication
Practices (ISMP) [PDF]
- A Uniform Color-Coding System for Topical
Ocular Medicine, Allan Jensen, MD, American Academy of
Ophthalmology
- Local Anesthetic Color Code, Frank Kyle,
American Dental Association [PPT]
- Use of Color on Pharmaceutical Product
Labels, Labeling and Packaging, Mary Ann McElligott, Ph.D., Novo
Nordisk [PPT]
- Use of Color on Pharmaceutical Packaging and Labeling, Eric
B. Sheinin, Ph.D., USP [PPT]
- Pharm.D., MBA, Thomas Willer, Ph.D, Hospira. [PPT]
For further information, contact Mary Gross at
GrossM@cder.fda.gov.
PDF requires the free Adobe
Acrobat Reader
Back
to Top
Back to Workshops
Date created: February 28, 2005, updated October 14, 2005 |
![](https://webarchive.library.unt.edu/eot2008/20081019161843im_/http://www.fda.gov/cder/templates/graphics/dot_clear.gif) |